Anteotech Ltd
ASX:ADO
Intrinsic Value
AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. [ Read More ]
The intrinsic value of one ADO stock under the Base Case scenario is 0.002 AUD. Compared to the current market price of 0.023 AUD, Anteotech Ltd is Overvalued by 89%.
Valuation Backtest
Anteotech Ltd
Run backtest to discover the historical profit from buying and selling ADO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Anteotech Ltd
Current Assets | 5.1m |
Cash & Short-Term Investments | 4.6m |
Receivables | 265.7k |
Other Current Assets | 198.9k |
Non-Current Assets | 2.3m |
PP&E | 2.3m |
Current Liabilities | 1.8m |
Accounts Payable | 628.6k |
Other Current Liabilities | 1.1m |
Non-Current Liabilities | 891.6k |
Long-Term Debt | 349.7k |
Other Non-Current Liabilities | 541.9k |
Earnings Waterfall
Anteotech Ltd
Revenue
|
526.8k
AUD
|
Operating Expenses
|
-15.7m
AUD
|
Operating Income
|
-15.2m
AUD
|
Other Expenses
|
3.7m
AUD
|
Net Income
|
-11.5m
AUD
|
Free Cash Flow Analysis
Anteotech Ltd
ADO Profitability Score
Profitability Due Diligence
Anteotech Ltd's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
Score
Anteotech Ltd's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
ADO Solvency Score
Solvency Due Diligence
Anteotech Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Anteotech Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ADO Price Targets Summary
Anteotech Ltd
Shareholder Return
ADO Price
Anteotech Ltd
Average Annual Return | 109.38% |
Standard Deviation of Annual Returns | 159.74% |
Max Drawdown | -95% |
Market Capitalization | 50.5m AUD |
Shares Outstanding | 2 408 440 064 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.
Contact
IPO
Employees
Officers
The intrinsic value of one ADO stock under the Base Case scenario is 0.002 AUD.
Compared to the current market price of 0.023 AUD, Anteotech Ltd is Overvalued by 89%.